Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-palmitoyl-L-cysteine is a small molecule characterized by a palmitoyl group attached to L-cysteine via a thioester linkage. This compound is a form of S-palmitoyl amino acid and an S-(long-chain fatty acyl)-L-cysteine. It is being investigated as a potential therapeutic agent for conditions such as Hashimoto's thyroiditis and recurrent miscarriage, having been identified through bioinformatics methods and molecular docking as a candidate drug. The broader biological process of S-palmitoylation, which involves the reversible covalent attachment of fatty acids to cysteine residues in proteins, plays a crucial role in modulating protein hydrophobicity, membrane association, subcellular trafficking, and protein-protein interactions, thereby influencing protein stability, function, and localization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on S-palmitoyl-L-cysteine.